You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 290 No. 8, August 27, 2003 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Medical News & Perspectives
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on ISI (1)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •World Health
 •Patient Safety/ Medical Error
 •Drug Therapy, Other
 •Alert me on articles by topic

Alarm Sounded on Fake, Tainted Drugs

Some Wholesalers Are a Weak Link in a Dangerous Chain

Brian Vastag

JAMA. 2003;290:1015-1016.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

It is one horror story of many: A father injects his son with human growth hormone, then discovers after the child complains of burning that the vials contain inexpensive insulin. Investigators traced the vials, which the father had purchased at a pharmacy in Orlando, Fla, to a large wholesaler. That wholesaler had acquired the ostensible growth hormone only after the shipment had been handled by three smaller distributors.


A US Customs Canine Enforcement Team working at an airport inspects international mail for illegal and possibly bogus medications purchased over the Internet. (Photo credit: James Tourtellotte/US Customs and Border Protection)

The originating company in this dangerous chain held no valid license, but because it had claimed to be an authorized distributor—that is, one that receives batches of pharmaceuticals directly from the manufacturer—it was under no obligation to identify the source of the drug. According to a Florida grand jury, . . . [Full Text of this Article]



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Counterfeit or substandard antimicrobial drugs: a review of the scientific evidence
Kelesidis et al.
J Antimicrob Chemother 2007;60:214-236.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.